HNPCC Pts May Reject Prophylactic Subtotal Colectomy

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 15 No 7
Volume 15
Issue 7

People with hereditary nonpolyposis colorectal cancer (HNPCC), are willing to consider the pros and cons of prophylactic subtotal colectomy to manage their disorder, but still have strong concerns about the procedure

AMELIA ISLAND, Florida—People with hereditary nonpolyposis colorectal cancer (HNPCC), are willing to consider the pros and cons of prophylactic subtotal colectomy to manage their disorder, but still have strong concerns about the procedure, according to a study presented at the American Psychosocial Oncology Society (APOS) Third Annual Conference (abstract P12-3).

Karen Hurley, PhD, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, interviewed 11 people with HNPCC about their willingness to undergo prophylactic subtotal colectomy: Fewer than half (45.5%) said they would consider the surgery even in the event of a diagnosis of colorectal cancer. A smaller percentage, 18.2%, said they would consider it even without a cancer diagnosis, and 36% said they would not consider it at all. For most (63.6%), not needing an annual colonoscopy was not considered enough of an incentive to have the surgery. Slightly more than half had never heard about the prophylactic surgery before their interview. They were more likely to know about it if they had already received a cancer diagnosis. "People with HNPCC should be considering the option of prophylactic subtotal colectomy before they get hit with a cancer diagnosis, so they can make informed and reasoned choices," Dr. Hurley said.

Related Videos
Immunotherapy may be an “elegant” method of managing colorectal cancer, says Gregory Charak, MD.
Administering neoadjuvant therapy to patients with colorectal cancer may help surgical oncologists attain a negative-margin resection.
Increasing screening for younger individuals who are at risk of colorectal cancer may help mitigate the rising early incidence of this disease.
Laparoscopy may reduce the degree of pain or length of hospital stay compared with open surgery for patients with colorectal cancer.
Quantifying disease volume to help identify potential recurrence following surgery may be a helpful advance, according to Sean Dineen, MD.
A panel of 5 experts on colorectal cancer
A panel of 5 experts on colorectal cancer
A panel of 5 experts on colorectal cancer
Treatment options in the refractory setting must improve for patients with resected colorectal cancer peritoneal metastasis, says Muhammad Talha Waheed, MD.
Arvind N. Dasari, MD, MS, an expert on colorectal cancer